The Latest Cardiac and Vascular News
Results show statistically significant decreases in stroke volume, edema, and necrotic area versus controls SAN DIEGO, Feb. 12, 2024 /PRNewswire/ — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular disease, presented data from a…
TEL AVIV, Israel and MIAMI, Feb. 12, 2024 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Carotid Stent System (EPS) for the prevention of stroke, today announced that the Company has appointed principal investigators (PIs) for its upcoming C-GUARDIANS II clinical trial of the SwitchGuard™ […]
BOSTON, Feb. 09, 2024 (GLOBE NEWSWIRE) — Balt, Inc., a global technology leader in neurovascular devices, today announced the presentation of preliminary data from The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma during the late-breaking session at the International […]
SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in neurovascular care. Six studies, presented at the International Stroke Conference (ISC) 2024, have shown positive outcomes with real-world impact of Viz.ai in clinical practice across various neurology pathologies including acute ischemic stroke, unruptured incidental aneurysm (UIA) and brain hemorrhage. “As a leader i
BOSTON, Feb. 7, 2024 /PRNewswire/ — CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that Dr. Pedro Lylyk, Director General of ENERI, will deliver a symposium presentation entitled, “Endovascular Shunting for…
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, will showcase its clinical expertise and industry-leading innovation at the American Heart Association’s International Stroke Conference (ISC) in Phoenix, AZ, February 7-9. Through various research presentations, […]
SAN MATEO, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio. The company offers a range of solutions […]
TEL AVIV, Israel and MIAMI, Dec. 20, 2023 (GLOBE NEWSWIRE) — InspireMD (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the issuance of U.S. Patent No. 11,844,893, titled, “Shunts with Blood Flow Indicators.” The patent covers key aspects of the […]
ALWAY, Ireland–(BUSINESS WIRE)–Perfuze, a private medical device company dedicated to developing pioneering technology to treat acute ischemic stroke, proudly announces FDA clearance for the Millipede 070 Aspiration Catheter and the 2nd generation of the Millipede 088 Access Catheter. “Perfuze aims to provide neurovascular interventionists with innovative thrombectomy solutions, to maximize their […]
FAIRFAX, Va., Dec. 13, 2023 /PRNewswire/ — The Society of NeuroInterventional Surgery (SNIS) congratulates SNIS President Mahesh Jayaraman, MD, FACR, on his promotion to Chair of the Department of Diagnostic Imaging at The Warren Alpert Medical School of Brown University and Chief of Diagnostic Imaging at Lifespan, effective January 1, 2024. He will also be appointed the Charles and Elfriede Collis-Frances Weeden Gibson Professor of Diagnostic Imaging.
“I’m thrilled to congratulate Dr. Jayaraman on this well-deserved promotion. His groundbreaking research, strong leadership, and endless dedication to pursuing excellence makes him an invaluable asset to our field,” said SNIS Executive Director Marie Williams Denslow. “We are very grateful for his hard work, contributions, and commitment to his patients, and wish him success in his new roles.”
Dr. Jayaraman is recognized as a pioneering interventional neuroradiologist; his work has been published in more than 150 peer-reviewed journal articles, books and book chapters. He also serves as a Professor of Diagnostic Imaging, Neurology, and Neurosurgery at The Warren Alpert Medical School and the Director of the Neurovascular Center at Rhode Island Hospital. Under his direction, the center has gained international acclaim for providing cutting-edge care for patients with cerebrovascular disease.
As president of SNIS, Dr. Jayaraman leads SNIS in all its endeavors to enhance the field. Together SNIS members work to promote research, standard-setting, education and advocacy regarding diagnosing and treating diseases of the brain, spine, head and neck. With more than 1,000 members worldwide, the society is committed to providing the highest quality of patient care through these minimally invasive procedures.
Outside of his clinical work, Dr. Jayaraman has helped lead the SNIS effort to update stroke protocols across the nation through the association’s Get Ahead of Stroke® campaign. These policy changes help ensure that patients experiencing a severe stroke are transported directly to a Level 1 stroke center by EMS personnel. He championed this work in Rhode Island, resulting in statewide policy changes in 2016.
About the Society of NeuroInterventional Surgery
The Society of NeuroInterventional Surgery (SNIS) is a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery through research, standard-setting, and education and advocacy to provide the highest quality of patient care in diagnosing and treating diseases of the brain, spine, head and neck. Visit www.snisonline.org and follow us on Twitter (@SNISinfo) and Facebook (@SNISOnline).
SOURCE The Society of NeuroInterventional Surgery (SNIS)
